INS and type 2 diabetes mellitus: Similarly, Alagiakrishnan et al. [145] indicates that T2DM therapies may improve cognitive function in AD patients, especially intranasal insulin has been shown to improve memory and cognitive abilities in mild cognitive impairment and AD patients.